Viewing Study NCT05974267


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-01-01 @ 1:30 AM
Study NCT ID: NCT05974267
Status: COMPLETED
Last Update Posted: 2025-10-08
First Post: 2023-07-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module